Skip to main content
Popup Login
HR Login
Sara Login
Login
Search
Search
Search
Enter the terms you wish to search for.
Footer
About Us
What is MSF
Where We Work
What We Do
Our Publications
Finances
MSF in India
Projects In India
Access Campaign
News & Stories
News From Our Projects
Stories From The Field
Statements & Opinions
Medical Research
Press Room
Get Involved
Individual Support
Corporate Support
Fundraise For MSF
Events
Campaigns
Donation Faq
Donor Stories
Work with us
Work with us
Work Overseas
Work in India (Projects)
Work in India (Office)
GHHM Course
Donate
Toggle navigation
Footer
About Us
What is MSF
Where We Work
What We Do
Our Publications
Finances
MSF in India
Projects In India
Access Campaign
News & Stories
News From Our Projects
Stories From The Field
Statements & Opinions
Medical Research
Press Room
Get Involved
Individual Support
Corporate Support
Fundraise For MSF
Events
Campaigns
Donation Faq
Donor Stories
HIV, multidrug-resistant TB and depressive symptoms:when three conditions collide
HIV, multidrug-resistant TB and depressive symptoms:when three conditions collide
September 01, 2014
Related
Universal health coverage in a regional Nepali hospital
March 21, 2013
Post Kala-Azar Dermal Leishmaniasis following treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) for Primary Visceral Leishmaniasis in Bihar, India
January 01, 2014
Risk factors for Visceral Leishmaniasis relapse in Immunocompetent patients following treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) in Bihar, India
January 01, 2014
Five-year field results and long-term effectiveness of 20 mg/kg Liposomal Amphotericin B (Ambisome) for Visceral Leishmaniasis in Bihar, India
January 01, 2014
HIV, multidrug-resistant TB and depressive symptoms:when three conditions collide
September 01, 2014
Kashmir Mental Health Survey
January 01, 2016
TB Briefing Paper - October 2016
October 01, 2016
Share
Facebook
Twitter
Googleplus
LinkedIn
Instagram